New Products

View all new products by date added

Search for new products by date added, alphabetically, or by pharmacological action.

New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules and peptides being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can. New products can be identified throughout the Tocris website by the symbol.

If you can't find what you are looking for we welcome new product suggestions. If you would like to be kept informed about new products by email, please sign up for our monthly e-alert service.

Cat. No. 产品名称/活性 Date Added
6863 N6-Cyclohexyladenosine Nov 2019
High affinity A1 receptor agonist
6870 AZ 12799734 Nov 2019
Potent TGF-βRI inhibitor
7013 OptoBI-1 Nov 2019
Photoswitchable TRPC3/6/7 agonist
7066 RCGD 423 Nov 2019
gp130 modulator; activates JAK/STAT signaling
7044 (±)-α-Lipoic acid Nov 2019
Liquid-liquid phase separated condensate modifier; reduces stress granule formation
6481 AP 14145 hydrochloride Nov 2019
KCa2 channel negative allosteric modulator
4265 AS 1842856 Nov 2019
Potent and selective Foxo1 inhibitor; orally bioavailable
6895 VU 0424465 Oct 2019
Potent mGlu5 positive allosteric modulator and agonist; binds allosteric site with high affinity
7065 Kainic acid (synthetic) Oct 2019
Kainate agonist; excitant and neurotoxin
7045 (±)-α-Lipoamide Oct 2019
Phase-separated condensate modifier; orally bioavailable
6574 Fluorescein-NAD+ Oct 2019
Fluorescent NAD+; substrate for ADP-ribosylation for use in PARP assays
6982 Cyclosporin H Oct 2019
Viral transduction enhancer
6936 VZ 185 Oct 2019
Potent and selective BRD7/9 Degrader
6932 VU 0467485 Oct 2019
Potent and selective positive allosteric modulator of M4 receptors; orally bioavailable and brain penetrant
6897 P110 Oct 2019
Dynamin-related protein 1 (Drp1) inhibitor; cell-permeable
6847 TAT-GluA2 3Y Oct 2019
Inhibitor of AMPA receptor endocytosis
6691 LP 922056 Oct 2019
Notum inhibitor; activates Wnt signaling
6974 BMS 986094 Oct 2019
Prodrug of HCV RNA polymerase inhibitor 2'-C-methyl guanosine triphosphate; potent HCV replication inhibitor
6940 BTD Oct 2019
Selective TRPC5 activator
6573 Biotin-NAD+ Oct 2019
Biotinylated-NAD+; substrate for ADP-ribosylation
7046 1,6-Hexanediol Sep 2019
Tool for probing liquid-liquid phase separation
7027 LY 2033298 Sep 2019
Selective positive allosteric modulator of M4 receptors; active in vivo; antipsychotic
7006 PDD 00017272 Sep 2019
Potent PARG inhibitor
6427 Tafluprost Sep 2019
Very high affinity FP receptor agonist
6821 ZAP 180013 Sep 2019
Zap70 inhibitor; inhibits interaction with ITAMs
7005 4-Thiouridine Sep 2019
Photoreactive uridine analog for RNA sequencing
5847 ZLD 1039 Sep 2019
Potent and selective EZH2 inhibitor; orally bioavailable
6970 aTAG 2139 Sep 2019
Degrader of MTH1 fusion proteins for use within the aTAG system
6797 KLD 12 Sep 2019
Self-assembling peptide; forms hydrogel to support cell growth
6764 B 973B Sep 2019
Positive allosteric modulator of α7 nAChRs; analgesic
6972 A 1899 Sep 2019
Potent K2P3.1 (TASK-1) and K2P9.1 (TASK-3) blocker
6950 Thalidomide - linker 11 Sep 2019
Thalidomide-PEG3-ethylamine
6889 ML 418 Sep 2019
Kir 7.1 inhibitor; also inhibits Kir 6.2
6857 BAY 293 Sep 2019
Potent KRas/SOS1 interaction inhibitor
6899 TH 257 Sep 2019
Potent and selective allosteric LIMK 1/2 inhibitor
6888 ML 402 Sep 2019
Selective TREK channel activator
7020 LDV Sep 2019
α4β1 (VLA-4) ligand
6803 MRK 740 Sep 2019
Potent PRDM9 inhibitor
6937 BSJ-04-132 Sep 2019
Selective Cdk4 degrader
6980 BAY 87-2243 Sep 2019
Mitochondrial complex I inhibitor
6906 BAY 293 Negative Control Sep 2019
Negative control for BAY 293 (Cat. No. 6857)
6893 VU 6005649 Sep 2019
Positive allosteric modulators of mGlu7 and mGlu8 receptors; also NK1 antagonist; brain penetrant
6765 JTP 103237 Aug 2019
Potent and selective monoacyglycerol acyltransferase 2 (MOGAT2) inhibitor
6938 BSJ-03-204 Aug 2019
Selective Cdk4/6 degrader
6201 J 2156 Aug 2019
Selective high affinity human sst4 agonist
6994 HODHBt Aug 2019
STAT5-SUMO protein-protein interaction inhibitor
6978 AZD 5363 Aug 2019
Potent pan-AKT inhibitor
6619 TFAX 488, SE Aug 2019
Green fluorescent dye; amine reactive
6927 Glucagon (Human, Porcine) Aug 2019
Endogenous glucagon receptor agonist
6930 Amphotericin B Aug 2019
Forms monovalent ion channels in lipid bilyers; antifungal
6859 FITM Aug 2019
Potent and selective negative allosteric modulator of mGlu1 receptors
6922 BSJ-Bump Aug 2019
Negative control for BSJ-03-123 (Cat. No. 6921)
6921 BSJ-03-123 Aug 2019
Selective Cdk6 degrader
6623 TFAX 546, SE Aug 2019
Yellow fluorescent dye; amine reactive
6109 Methylnaltrexone bromide Aug 2019
μ antagonist; peripherally restricted
6054 R162 Aug 2019
Glutamate dehydrogenase (GDH1) inhibitor
5861 ARN 726 Aug 2019
Potent N-acylethanolamine acid amidase (NAAA) inhibitor; NAAA activity-based protein profiling (ABPP) probe
6902 OLT 1177 Jul 2019
NLRP3 inflammasome inhibitor; disrupts inflammasome formation
6823 CycLuc 1 Jul 2019
Synthetic luciferase substrate; brain penetrant; displays NIR emission
6954 L-Buthionine sulfoximine Jul 2019
Irreversible γ-glutamylcysteine synthetase (γ-GCS) inhibitor; induces ferroptosis
6776 G5 Jul 2019
Ubiquitin isopeptidase inhibitor; induces apoptosis
6751 (R)-(-)-Ketamine hydrochloride Jul 2019
NMDA antagonist; antidepressant; may not display psychotomimetic or addictive side effects of (S)-ketamine
6986 EG 00229 trifluoroacetate Jul 2019
Neuropilin 1 (NRP1) receptor antagonist; inhibits VEGFA binding to NRP1
6886 ML 67-33 Jul 2019
K2P2.1 (TREK-1), K2P10.1 (TREK-2) and K2P4.1 (TRAAK) channel activator
6933 CM 10 Jul 2019
ALDH1A inhibitor; depletes CD133+ cancer stem cells
6920 SAH-SOS1A Jul 2019
KRas/SOS1 interaction inhibitor
6701 1A-116 Jul 2019
Rac1 inhibitor; blocks Rac1-P-Rex1 interaction
6757 t-TUCB Jul 2019
Potent soluble epoxide hydrolase (sEH) Inhibitor; anti-inflammatory and antinociceptive
6904 Idasanutlin Jul 2019
Potent MDM2 inhibitor; inhibits MDM2-p53 interaction
6924 Oridonin Jul 2019
High affinity NLRP3 inflammasome inhibitor
6703 BGP 15 Jul 2019
PARP inhibitor; cytoprotectant
6909 VH 032 phenol - linker 1 Jul 2019
VH 032 phenol-alkylC4-amine
6969 cis VH 032, amine dihydrochloride Jul 2019
Negative control for VH 032, amine (Cat. No. 6462)
6910 VH 032 phenol - linker 2 Jul 2019
VH 032 phenol-alkylC6-amine
6500 Janelia Fluor® 549, Maleimide Jul 2019
Cell permeable yellow fluorescent dye; supplied with a maleimide reactive group
6228 H10 Jul 2019
PARP14 inhibitor; cell-permeable
6903 DPTIP Jul 2019
Potent and selective N-SMase2 inhibitor; brain penetrant
6884 TC SL C5 Jul 2019
Metastasis-associated lung adenocarcinoma transcript 1 (Malat1) RNA inhibitor
6801 Tocriscreen Epigenetics Library Jul 2019
A library of 101 epigenetic compounds (250 μL, 10 mM DMSO solutions)
6790 GSK 126 Jul 2019
Very high affinity and selective EZH2 inhibitor
6960 ABT 199 Jul 2019
Selective, high affinity Bcl-2 inhibitor; orally bioavailable
6877 VU 0134992 Jul 2019
Kir4.1 blocker
6908 TR 14035 Jul 2019
Potent integrin α4β7 and α4β1 (VLA-4) antagonist; orally bioavailable
6874 AMG 333 Jul 2019
Potent and selective TRPM8 antagonist; active in vivo
6956 Galunisertib Jun 2019
ALK4 and ALK5 (TGFβRI) inhibitor
6934 673 A Jun 2019
ALDH1A inhibitor; depletes CD133+ cancer stem cells (CSC)
6957 Reparixin L-lysine salt Jun 2019
Potent CXCR1 and CXCR2 allosteric antagonist
6521 I-BET 762 Jun 2019
Potent and high affinity BRD inhibitor; anti-inflammatory; orally bioavailable.
6966 Thalidomide - linker 13 Jun 2019
Thalidomide-PEG1-ethylamine
6968 Thalidomide - linker 15 Jun 2019
Thalidomide-alkylC6-amine
6887 ML 335 Jun 2019
Selective K2P2.1 (TREK-1) and K2P10.1 (TREK-2) activator
6967 Thalidomide - linker 14 Jun 2019
Thalidomide-PEG2-ethylamine
6561 BAY 6035 Jun 2019
Potent and selective SMYD3 inhibitor
6948 CRBN-6-5-5-VHL Jun 2019
Potent and selective cereblon degrader; cell-permeable
6905 Ceritinib Jun 2019
Highly potent ALK inhibitor; also potently inhibits IR, IGF1R, STK22D and FLT3
6917 Thalidomide - linker 9 Jun 2019
Thalidomide-alkylC4-amine
6713 ZXH 3-26 Jun 2019
Potent and selective BRD4 degrader
6716 Pomalidomide - linker 4 Jun 2019
Pomalidomide-alkylC5-amine
6489 Ocean Blue, SE Jun 2019
Blue fluorescent dye; supplied as NHS ester
6963 Pomalidomide - linker 8 Jun 2019
Pomalidomide-PEG4-ethylamine
6854 LY 3009120 Jun 2019
Potent pan-Raf kinase inhibitor
6837 GSK 923295A May 2019
Potent and selective centromere associated protein E (CENP-E) allosteric inhibitor
6885 PU 23 May 2019
Multidrug resistance protein (MRP) 4 inhibitor
6665 BI 9321 May 2019
Nuclear receptor-binding SET domain (NSD) 3 antagonist; selectively binds PWWP1 domain
6778 S 38093 May 2019
Selective H3 antagonist and inverse agonist; also σ1 receptor antagonist; antinociceptive
6495 AM 12 May 2019
TRPC5 inhibitor
6926 Fenoprofen calcium May 2019
Positive allosteric modulator of MC3 receptors; exhibits biased signaling
6872 BQCA May 2019
Positive allosteric modulator of M1 receptors
6891 PND 1186 May 2019
Potent FAK inhibitor; orally bioavailable
6493 A 317491 sodium salt May 2019
Selective, high affinity P2X3 and P2X2/3 receptor antagonist; antinociceptive
6433 GSK 1016790A May 2019
Potent TRPV4 agonist; active in vivo
6898 Mitochondrial fusion promoter M1 May 2019
Mitochondrial fusion promoter
6835 ABT 737 May 2019
Bcl-2 family inhibitor; mimics BH3 and induces apoptosis in cancer cell lines
6782 Indisulam May 2019
Molecular glue; pre-mRNA splicing modulator
6313 A 33 May 2019
Potent and selective PDE4B inhibitor
6861 Anle138b May 2019
Oligomeric aggregation inhibitor; inhibits prion protein and α-synuclein aggregate formation
6817 BAY 8002 May 2019
Potent dual MCT1/2 inhibitor; orally bioavailable